Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionContact Us   |  Subscribe   |  Advertise   |  Login  Page layout
Wide layoutNarrow layoutFull screen layout
Lung India Official publication of Indian Chest Society  
  Users Online: 179   Home Print this page  Email this page Small font size Default font size Increase font size
Year : 2019  |  Volume : 36  |  Issue : 3  |  Page : 216-225

Pneumococcal disease burden from an Indian perspective: Need for its prevention in pulmonology practice

1 Department of Internal & Pulmonary Medicine, SKIMS Hospital, Srinagar, Jammu and Kashmir, India
2 Department of T.B. & Chest, Dr. Murari Lal Chest Hospital, GVSM Medical College, Kanpur, Uttar Pradesh, India
3 Department of Pulmonary, Critical Care & Sleep Medicine, Norvic International Hospital, Kathmandu, Nepal
4 Department of Pulmonary Medicine, Christian Medical College Hospital, Vellore, Tamil Nadu, India
5 Department of Respiratory Medicine, Fortis Hospital, Kolkata, West Bengal, India
6 Department of Pulmonary Medicine, Dr. Kumar Doshi Clinic, Kolkata, West Bengal, India
7 Department of Pulmonary Medicine, National Allergy Asthma Bronchitis Institute, Kolkata, West Bengal, India
8 Department of T.B. & Chest, Geetanjali Medicity, Eklingpura, Rajasthan, India
9 Department of Chest Medicine, Hinduja Hospital, Mumbai, Maharashtra, India
10 Department of Pulmonary, Critical Care and Sleep Medicine, Apollo Speciality Hospital, Mumbai, Maharashtra, India
11 Department of Chest Medicine, Bombay Hospital, Mumbai, Maharashtra, India
12 Department of Medicine, Anwer Khan Modern Medical College, Dhaka, Bangladesh
13 Respiratory, Critical Care & Sleep Medicine, Getwell Hospital, Nagpur, Maharashtra, India

Correspondence Address:
Dr. Parvaiz A Koul
SKIMS Hospital, Srinagar, Jammu and Kashmir
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/lungindia.lungindia_497_18

Rights and Permissions

Globally, pneumococcal diseases are a significant public health concern. They are preventable and frequently occur among older adults. Major risk factors for the disease are extremes of age, alcohol intake, smoking, air pollution, and comorbid conditions (diabetes, chronic obstructive pulmonary disease, chronic kidney disease, liver disease, and heart disease). Risk factors, coupled with limited disease-burden data and the emergence of antibiotics resistance, are hindering the effective management of the disease in older adults. Various global guidelines recommend pneumococcal vaccines for the prevention of pneumococcal diseases, as they reduce disease burden, hospitalization, and mortality rates among patients with comorbid conditions. Besides being an integral part of childhood immunization, these vaccines are advocated by various Indian healthcare bodies/groups for older and younger adults with certain medical conditions. The article presents an overview of the closed-door discussion by the Indian pulmonary experts on the scientific evidence and clinical practice followed for the prevention of pneumococcal disease in India.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded322    
    Comments [Add]    

Recommend this journal